Severe Psoriasis Presenting in 3-Year-Old Child With Nail Dystrophy: Response to Biologic Treatment
Psoriasis, a chronic inflammatory skin condition, affects about 2% of children. A small subset have isolated nail involvement refractory to topical treatment that can be disabling. The development of targeted biologic agents offers safe, effective options for children with moderate-to-severe skin and nail disease. A few are now Food and Drug Administration (FDA)-approved for children.
INTRODUCTIO …
![psoriasis](https://nextstepsinderm.com/wp-content/uploads/2022/11/Sevevere-Psoriasis_CaseReport.png)
![psoriasis](https://nextstepsinderm.com/wp-content/uploads/2022/11/Sevevere-Psoriasis_CaseReport.png)